- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
RAD
For Q2 Earnings, Rite Aid Stock Must Bank on Positive Guidance
With Rite Aid reporting Q2 earnings on Thursday, all eyes will focus on the pharmacy retailer’s forward guidance. Unfortunately, that might not be a good thing for RAD stock.
A New CEO is One Reason Why Rite Aid’s Long-Term Prospects are Improving
Rite Aid stock has a chance of recovering but the new CEO has plenty of work ahead. The company must grow prescription volumes and sales.
Stock Market Today: Sleepy Session as Earnings Lurk Ahead
It was a slow session in the stock market today, with little gains showing up on Monday. Here's what happened in the U.S. stock market.
New CEO Heyward Donigan Needs a Miracle to Revive Rite Aid Stock
RAD stock looks tempting here in the midst of this lull, but what Rite Aid needs to do the most is the one thing that will be toughest to do.
Why Rite Aid Stock Will Probably Underperform Alternatives
With the RAD stock price down 95%, value investors might be intrigued. But there are better risk-adjusted plays than Rite Aid stock.
For Rite Aid Stock, Everything Depends on Millennials
As with most investments, the future of Rite Aid stock depends on millennials. Here, new Rite Aid CEO Heyward Donigan has both an opportunity as well as significant risks.
Even After Recent Gains Rite Aid Stock Is Still Underweight
Despite its cheap price, Rite Aid stock is hardly what you would call a discount. Instead, it’s a junk equity that you should steer clear from, considering that it doesn’t have an Amazon Counter-like catalyst in the foreseeable future.
It’s Still Too Risky to Bet on Rite Aid Stock
RAD stock is coming off of its best seven-day stretch in five years, but this rally may mean nothing in Rite Aid's bigger picture.
With 3 New Growth Catalysts, Is Rite Aid Stock Finally a Buy?
RAD stock has been in an awful downtrend... for 15 years. But there's still some value and opportunity here.
Is Rite Aid Stock the Best Play Under $6?
Having been gutted in the markets over the years, Rite Aid stock appeals to risk-tolerant contrarians. However, there are other names with similar upside potential but with much more stable fundamentals.
Rite Aid Stock Is Risky but Could Pay Off
Rite Aid stock is not for the faint of heart, but RAD stock could surprise the critics and enrich the intrepid.
Rite Aid Stock Continues to Fade into Irrelevance Despite Amazon
The Amazon deal with Rite Aid has only made RAD stock temporarily interesting. But to sustain momentum, the pharmacy needs a much deeper partnership with the e-commerce giant.
Don’t Count on Amazon to Save Rite Aid Stock Just Yet
A unique Amazon partnership provides a glimmer of hope for RAD stock, but don't bet on that glimmer of hope until it gets brighter.
New Rite Aid CEO Needs More Than Amazon Partnership to Drive RAD Stock Higher
Heyward Donigan isn't the reason RAD stock has tanked of late. But, if she doesn't appreciate where Rite Aid is wasting money, she may be the reason Rite Aid stock continues to lose ground.
Think Amazon Will Save Rite Aid Stock? Think Again.
A package pick-up service sounds promising for Rite Aid, but just like the RAD stock price chart, it’s an uphill battle.
Maybe Amazon Will Wake up Rite Aid Stock, but It’s a Risky Bet
The Amazon catalyst gives RAD stock unique breakout potential from today's depressed levels, but that potential is accompanied by ample risk.
Take a Deeper Look at Rite Aid Stock and the Amazon Deal
Fundamentally, speculators in Rite Aid stock are ignoring the demographic tailwind that the retail pharmacy’s deal with Amazon provides.
Investors Shouldn’t Gamble on Rite Aid Stock
Rite Aid’s partnership with Amazon might have put some life in the RAD stock price, but Rite Aid stock is still nothing but cheap trash.
The Worst Appears to Be Over for CVS Stock
Over the years, CVS stock has incurred some painful losses in the markets. However, bold moves by management make this a compelling contrarian buy.
